Rigel Pharmaceuticals (RIGL) Change in Account Payables (2010 - 2026)
Rigel Pharmaceuticals' quarterly Change in Account Payables came in at -$2.7 million in Q1 2026, down 539.84% year-on-year from $615000.0 in Q1 2025, and down 180.87% quarter-over-quarter from $3.3 million in Q4 2025.
Rigel Pharmaceuticals has reported Change in Account Payables for 17 years, with the latest figure at -$2.7 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 539.84% year-over-year to -$2.7 million; the trailing twelve-month figure through Mar 2026 stood at $532000.0 (up 110.0% YoY), and the FY2025 full-year result was $3.9 million, up 201.29% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$2.7 million, down from $3.3 million in the prior quarter.
- The five-year high for Change in Account Payables was $4.8 million in Q4 2022, with the low at -$3.4 million in Q3 2025.
- Average Change in Account Payables over 5 years is $45058.8, with a median of -$476000.0 recorded in 2024.
- Year-over-year, Change in Account Payables surged 802.73% in 2025 and sank 539.84% in 2026.
- Tracing RIGL's Change in Account Payables over 5 years: stood at $4.8 million in 2022, then tumbled by 117.9% to -$857000.0 in 2023, then jumped by 44.46% to -$476000.0 in 2024, then surged by 802.73% to $3.3 million in 2025, then plunged by 180.87% to -$2.7 million in 2026.
- The last three Change in Account Payables figures came in at -$2.7 million (Q1 2026), $3.3 million (Q4 2025), and -$3.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | -2.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.71 Mn |
| Mar 31, 2026 | -2.71 Mn |
| Dec 31, 2025 | 3.35 Mn |
| Dec 31, 2025 | 3.35 Mn |
| Sep 30, 2025 | -3.44 Mn |
| Sep 30, 2025 | -3.44 Mn |
| Jun 30, 2025 | 3.34 Mn |
| Jun 30, 2025 | 3.34 Mn |
| Mar 31, 2025 | 615,000.00 |
| Mar 31, 2025 | 615,000.00 |
| Dec 31, 2024 | -476,000.00 |
| Dec 31, 2024 | -476,000.00 |
| Sep 30, 2024 | -2.32 Mn |
| Sep 30, 2024 | -2.32 Mn |
| Jun 30, 2024 | -3.15 Mn |
| Jun 30, 2024 | -3.15 Mn |
| Mar 31, 2024 | 2.13 Mn |
| Mar 31, 2024 | 2.13 Mn |
| Dec 31, 2023 | -857,000.00 |
| Dec 31, 2023 | -857,000.00 |
| Sep 30, 2023 | 2.76 Mn |
| Sep 30, 2023 | 2.76 Mn |
| Jun 30, 2023 | -1.06 Mn |
| Jun 30, 2023 | -1.06 Mn |
| Mar 31, 2023 | -1.21 Mn |
| Mar 31, 2023 | -1.21 Mn |
| Dec 31, 2022 | 4.79 Mn |
| Dec 31, 2022 | 4.79 Mn |
| Sep 30, 2022 | 586,000.00 |
| Sep 30, 2022 | 586,000.00 |
| Jun 30, 2022 | -2.44 Mn |
| Jun 30, 2022 | -2.44 Mn |
| Mar 31, 2022 | 850,000.00 |
| Mar 31, 2022 | 850,000.00 |
| Dec 31, 2021 | 697,000.00 |
| Dec 31, 2021 | 697,000.00 |
| Sep 30, 2021 | 1.37 Mn |
| Sep 30, 2021 | 1.37 Mn |
| Jun 30, 2021 | -3.42 Mn |
| Jun 30, 2021 | -3.42 Mn |
| Mar 31, 2021 | 1.39 Mn |
| Mar 31, 2021 | 1.39 Mn |
| Dec 31, 2020 | 1.54 Mn |
| Dec 31, 2020 | 1.54 Mn |
| Sep 30, 2020 | -1.13 Mn |
| Sep 30, 2020 | -1.13 Mn |
| Jun 30, 2020 | 1.21 Mn |
| Jun 30, 2020 | 1.21 Mn |
| Mar 31, 2020 | -1.95 Mn |
| Mar 31, 2020 | -1.95 Mn |
| Dec 31, 2019 | 1.49 Mn |
| Dec 31, 2019 | 1.49 Mn |
| Sep 30, 2019 | -1.12 Mn |
| Sep 30, 2019 | -1.12 Mn |
| Jun 30, 2019 | 2.60 Mn |
| Jun 30, 2019 | 2.60 Mn |
| Mar 31, 2019 | -5.21 Mn |
| Mar 31, 2019 | -5.21 Mn |
| Dec 31, 2018 | 3.75 Mn |
| Dec 31, 2018 | 3.75 Mn |
| Sep 30, 2018 | -701,000.00 |
| Sep 30, 2018 | -701,000.00 |
| Jun 30, 2018 | 1.20 Mn |
| Jun 30, 2018 | 1.20 Mn |
| Mar 31, 2018 | -493,000.00 |
| Mar 31, 2018 | -493,000.00 |
| Dec 31, 2017 | 443,000.00 |
| Dec 31, 2017 | 443,000.00 |
| Sep 30, 2017 | 118,000.00 |
| Sep 30, 2017 | 118,000.00 |
| Jun 30, 2017 | 877,000.00 |
| Jun 30, 2017 | 877,000.00 |
| Mar 31, 2017 | -4.39 Mn |
| Mar 31, 2017 | -4.39 Mn |
| Dec 31, 2016 | 4.05 Mn |
| Dec 31, 2016 | 4.05 Mn |
| Sep 30, 2016 | 18,000.00 |
| Sep 30, 2016 | 18,000.00 |
| Jun 30, 2016 | -924,000.00 |
| Jun 30, 2016 | -924,000.00 |
| Mar 31, 2016 | -339,000.00 |
| Mar 31, 2016 | -339,000.00 |
| Dec 31, 2015 | 2.07 Mn |
| Dec 31, 2015 | 2.07 Mn |
| Sep 30, 2015 | -407,000.00 |
| Sep 30, 2015 | -407,000.00 |
| Jun 30, 2015 | -40,000.00 |
| Jun 30, 2015 | -40,000.00 |
| Mar 31, 2015 | -477,000.00 |
| Mar 31, 2015 | -477,000.00 |
| Dec 31, 2014 | 595,000.00 |
| Dec 31, 2014 | 595,000.00 |
| Sep 30, 2014 | -878,000.00 |
| Sep 30, 2014 | -878,000.00 |
| Jun 30, 2014 | 739,000.00 |
| Jun 30, 2014 | 739,000.00 |
| Mar 31, 2014 | -2.75 Mn |
| Mar 31, 2014 | -2.75 Mn |
| Dec 31, 2013 | 2.88 Mn |
| Dec 31, 2013 | 2.88 Mn |
| Sep 30, 2013 | -1.10 Mn |
| Sep 30, 2013 | -1.10 Mn |
| Jun 30, 2013 | -17,000.00 |
| Jun 30, 2013 | -17,000.00 |
| Mar 31, 2013 | 441,000.00 |
| Mar 31, 2013 | 441,000.00 |
| Dec 31, 2012 | 309,000.00 |
| Dec 31, 2012 | 309,000.00 |
| Sep 30, 2012 | -524,000.00 |
| Sep 30, 2012 | -524,000.00 |
| Jun 30, 2012 | -10,000.00 |
| Jun 30, 2012 | -10,000.00 |
| Mar 31, 2012 | 366,000.00 |
| Mar 31, 2012 | 366,000.00 |
| Dec 31, 2011 | 281,000.00 |
| Dec 31, 2011 | 281,000.00 |
| Sep 30, 2011 | -186,000.00 |
| Sep 30, 2011 | -186,000.00 |
| Jun 30, 2011 | 189,000.00 |
| Jun 30, 2011 | 189,000.00 |
| Mar 31, 2011 | -131,000.00 |
| Mar 31, 2011 | -131,000.00 |
| Dec 31, 2010 | -1.59 Mn |
| Dec 31, 2010 | -1.59 Mn |
| Sep 30, 2010 | -59,000.00 |
| Sep 30, 2010 | -59,000.00 |